Search Results

There are 21363 results for: content related to: MAO Inhibitory Activity of 2-Arylbenzofurans versus 3-Arylcoumarins: Synthesis, in vitro Study, and Docking Calculations

  1. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies

    ChemMedChem

    Volume 7, Issue 3, March 5, 2012, Pages: 464–470, Dr. Dolores Viña, Dr. Maria J. Matos, Dr. Giulio Ferino, Prof. Enzo Cadoni, Dr. Reyes Laguna, Prof. Fernanda Borges, Prof. Eugenio Uriarte and Prof. Lourdes Santana

    Version of Record online : 27 JAN 2012, DOI: 10.1002/cmdc.201100538

  2. cis-cyclopropylamines as mechanism-based inhibitors of monoamine oxidases

    The FEBS Journal

    Volume 282, Issue 16, August 2015, Pages: 3190–3198, Thomas Malcomson, Kemal Yelekci, Maria Teresa Borrello, A. Ganesan, Elena Semina, Norbert De Kimpe, Sven Mangelinckx and Rona R. Ramsay

    Version of Record online : 27 MAR 2015, DOI: 10.1111/febs.13260

  3. Monoamine Oxidase (MAO) Inhibitory Activity: 3-Phenylcoumarins versus 4-Hydroxy-3-phenylcoumarins

    ChemMedChem

    Volume 9, Issue 8, August 2014, Pages: 1672–1676, Dr. Giovanna L. Delogu, Dr. Silvia Serra, Dr. Elias Quezada, Prof. Eugenio Uriarte, Dr. Santiago Vilar, Dr. Nicholas P. Tatonetti and Dr. Dolores Viña

    Version of Record online : 29 APR 2014, DOI: 10.1002/cmdc.201402010

  4. Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 5, May 2014, Pages: 677–687, Anél Petzer, Paul Grobler, Jacobus J. Bergh and Jacobus P. Petzer

    Version of Record online : 9 DEC 2013, DOI: 10.1111/jphp.12193

  5. Indanones As High-Potency Reversible Inhibitors of Monoamine Oxidase

    ChemMedChem

    Volume 10, Issue 5, May 2015, Pages: 862–873, Samantha Mostert, Prof. Anél Petzer and Prof. Jacobus P. Petzer

    Version of Record online : 27 MAR 2015, DOI: 10.1002/cmdc.201500059

  6. Interactions of monoamine oxidase with substrates and inhibitors

    Medicinal Research Reviews

    Volume 9, Issue 1, January/March 1989, Pages: 45–89, Philippe L. Dostert, Margherita Strolin Benedetti and Keith F. Tipton

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610090104

  7. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation

    ChemMedChem

    Volume 11, Issue 11, June 6, 2016, Pages: 1145–1160, Rati K. P. Tripathi, Gopal K. Rai and Dr. Senthil R. Ayyannan

    Version of Record online : 2 MAY 2016, DOI: 10.1002/cmdc.201600128

  8. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism

    Medicinal Research Reviews

    Volume 15, Issue 4, July 1995, Pages: 325–388, Amit S. Kalgutkar, Neal Castagnoli Jr. and Bernard Testa

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610150406

  9. You have free access to this content
    Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver

    British Journal of Pharmacology

    Volume 121, Issue 5, July 1997, Pages: 901–912, Andrés Ozaita, Gabriel Olmos, M Assumpció Boronat, José Miguel Lizcano, Mercedes Unzeta and Jesús A García-Sevilla

    Version of Record online : 10 FEB 2009, DOI: 10.1038/sj.bjp.0701214

  10. Structure and Mechanism of Monoamine Oxidase

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    D. E. Edmondson, A. Mattevi, C. Binda, M. Li and F. Hubálek

    Published Online : 15 APR 2005, DOI: 10.1002/0471266949.bmc111

  11. The Synthesis and Evaluation of C7-Substituted α-Tetralone Derivatives as Inhibitors of Monoamine Oxidase

    Chemical Biology & Drug Design

    Volume 86, Issue 4, October 2015, Pages: 895–904, Lesetja J. Legoabe, Anél Petzer and Jacobus P. Petzer

    Version of Record online : 31 JAN 2015, DOI: 10.1111/cbdd.12508

  12. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 8, August 2015, Pages: 1267–1278, Jin Yong Chung, Ji Won Lee, Choon Ho Ryu, Hye Kyung Min, Yeo Jin Yoon, Mi Jung Lim and Cheol Hyoung Park

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jnr.23577

  13. You have free access to this content
    The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition

    The FEBS Journal

    Volume 278, Issue 24, December 2011, Pages: 4860–4869, Erika M. Milczek, Claudia Binda, Stefano Rovida, Andrea Mattevi and Dale E. Edmondson

    Version of Record online : 3 NOV 2011, DOI: 10.1111/j.1742-4658.2011.08386.x

  14. Design and Synthesis of a MAO-B-Selectively Activated Prodrug Based on MPTP: A Mitochondria-Targeting Chemotherapeutic Agent for Treatment of Human Malignant Gliomas

    ChemMedChem

    Volume 10, Issue 4, April 2015, Pages: 621–628, Prof. Dr. Martyn A. Sharpe, Dr. Junyan Han, Alexandra M. Baskin and Prof. Dr. David S. Baskin

    Version of Record online : 11 FEB 2015, DOI: 10.1002/cmdc.201402562

  15. You have free access to this content
    Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition

    British Journal of Pharmacology

    Volume 127, Issue 4, June 1999, Pages: 869–876, Virgili Pérez, José Luis Marco, Eldiberto Fernández-Álvarez and Mercedes Unzeta

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0702600

  16. Insight into the Functional and Structural Properties of 3-Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition

    ChemMedChem

    Volume 9, Issue 7, July 2014, Pages: 1488–1500, Dr. Maria João Matos, Dr. Santiago Vilar, Dr. Verónica García-Morales, Dr. Nicholas P. Tatonetti, Prof. Eugenio Uriarte, Prof. Lourdes Santana and Prof. Dolores Viña

    Version of Record online : 8 APR 2014, DOI: 10.1002/cmdc.201300533

  17. Design, Synthesis, in vitro MAO-B Inhibitory Evaluation, and Computational Studies of Some 6-Nitrobenzothiazole-Derived Semicarbazones

    ChemMedChem

    Volume 8, Issue 3, March 2013, Pages: 462–474, Rati K. P. Tripathi, Omprakash Goshain and Senthil Raja Ayyannan

    Version of Record online : 16 JAN 2013, DOI: 10.1002/cmdc.201200484

  18. Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group

    ChemMedChem

    Volume 11, Issue 14, July 19, 2016, Pages: 1551–1567, Rati K. P. Tripathi and Dr. Senthil R. Ayyannan

    Version of Record online : 22 JUN 2016, DOI: 10.1002/cmdc.201600202

  19. Clinical Pharmacology of Rasagiline: A Novel, Second-Generation Propargylamine for the Treatment of Parkinson Disease

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 878–894, Dr Jack J. Chen and Dr David M. Swope

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005277935

  20. You have free access to this content
    Phe208 and Ile199 in Human Monoamine Oxidase A and B Do Not Determine Substrate and Inhibitor Specificities as in Rat

    Journal of Neurochemistry

    Volume 75, Issue 3, September 2000, Pages: 1304–1309, Rani Maurice Geha , Kevin Chen and Jean Chen Shih

    Version of Record online : 11 DEC 2002, DOI: 10.1046/j.1471-4159.2000.751304.x